Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yu-ichiro Ohnishi is active.

Publication


Featured researches published by Yu-ichiro Ohnishi.


Genes to Cells | 2002

Inhibition of Nodal signalling by Lefty mediated through interaction with common receptors and efficient diffusion

Rui Sakuma; Yu-ichiro Ohnishi; Chikara Meno; Hideta Fujii; Hou Juan; Jun Takeuchi; Toshihiko Ogura; En Li; Kohei Miyazono; Hiroshi Hamada

Background: Two TGFβ‐related proteins, Nodal and Lefty, are implicated in early embryonic patterning of vertebrates. Genetic data suggest that Nodal is a signalling molecule, while Lefty is an antagonist of Nodal, but their precise function remains unknown.


Neuroreport | 2008

Transplantation of olfactory mucosa following spinal cord injury promotes recovery in rats.

Koichi Iwatsuki; Toshiki Yoshimine; Haruhiko Kishima; Masanori Aoki; Kazuhiro Yoshimura; Masahiro Ishihara; Yu-ichiro Ohnishi; Carlos Lima

Several recent studies have demonstrated the potential therapeutic role of olfactory ensheathing cells in spinal cord injury. The aim of this study was to elucidate whether grafts of nasal olfactory mucosa containing olfactory ensheathing cells can repair the injured rat spinal cord as compared with the nasal respiratory mucosa containing no olfactory ensheathing cells. These grafts were then transplanted into the partially removed rat spinal cord. Compared with the respiratory mucosa-transplanted rats, the olfactory mucosa-transplanted rats partially recovered the movement of their hindlimbs and joints. Corticospinal tracing indicated that olfactory mucosa transplantation restored the severed tract. Therefore, olfactory mucosa has potential value in the repair of spinal cord injury.


Orthopaedic Surgery | 2014

Isthmus-guided Cortical Bone Trajectory for Pedicle Screw Insertion

Koichi Iwatsuki; Toshiki Yoshimine; Yu-ichiro Ohnishi; Kosi Ninomiya; Toshika Ohkawa

Herein is described cortical bone trajectory (CBT), a new path for pedicle screw insertion for lumbar vertebral fusion. Because the points of insertion are under the end of the inferior articular process, and because the screws are inserted toward the lateral side, there is less soft tissue development than with the conventional technique; the CBT technique therefore enables less invasive surgery than the conventional technique. However, it has some drawbacks. For example, in the original CBT approach, the points of insertion are in the vicinity of the end of the inferior articular process. Because this joint has been destroyed in many patients who have indications for intervertebral fusion surgery, it is sometimes difficult to use it as a reference point for screw insertion location. With severe lateral slippage, the screw insertion site can become significantly dislocated sideways, with possible resultant damaging to the spinal canal and/or nerve root. The CBT technique here involved inserting the screws while keeping clear of the intervertebral foramen with the assistance of side view X‐ray fluoroscopy and using the end of the inferior articular process and the isthmus as points of reference for screw location.


Stem Cell Research | 2013

Adult olfactory sphere cells are a source of oligodendrocyte and Schwann cell progenitors

Yu-ichiro Ohnishi; Koichi Iwatsuki; Koei Shinzawa; Masahiro Ishihara; Takashi Moriwaki; Masao Umegaki; Haruhiko Kishima; Toshiki Yoshimine

The olfactory epithelial layer contains multipotent horizontal basal cells (HBCs) that differentiate into olfactory sensory neurons. Here, we show that rat HBCs express oligodendrocyte progenitor cell (OPC) and astrocyte markers. We generated olfactory sphere (OS) cells in cultures that were derived from adult rat olfactory mucosa. Fluorescence-activated cell sorting and immunofluorescence analyses showed that OS cells also express OPC and astrocyte markers. Interestingly, OS cells underwent oligodendrocyte differentiation in vitro. To study oligodendrocyte differentiation in vivo, OS cells were transplanted into injured rat spinal cords. The transplanted cells integrated into host tissue and differentiated into oligodendrocytes. When transected saphenous nerve ends were encased in collagen-containing silicone tubes with or without OS cells, the transplanted OS cells differentiated into Schwann cells. Our data provide new insights into of the stemness of OS cells.


Journal of Neurosurgery | 2015

Intranasal delivery of bone marrow stromal cells to spinal cord lesions

Koshi Ninomiya; Koichi Iwatsuki; Yu-ichiro Ohnishi; Toshika Ohkawa; Toshiki Yoshimine

OBJECT The intranasal delivery of bone marrow stromal cells (BMSCs) or mesenchymal stem cells to the injured brains of rodents has been previously reported. In this study, the authors investigated whether BMSCs migrate to spinal cord lesions through an intranasal route and whether the administration affected functional recovery. METHODS Forty Sprague-Dawley rats that were subjected to spinal cord injuries at the T7-8 level were divided into 5 groups (injured + intranasal BMSC-treated group, injured + intrathecal BMSC-treated group, injured-only group, injured + intranasal vehicle-treated group, and injured + intrathecal vehicle-treated group). The Basso-Beattie-Bresnahan (BBB) scale was used to assess hind limb motor functional recovery for 2 or 4 weeks. Intralesionally migrated BMSCs were examined histologically and counted at 2 and 4 weeks. To evaluate the neuroprotective and trophic effects of BMSCs, the relative volume of the lesion cavity was measured at 4 weeks. In addition, nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) levels in the CSF were evaluated at 2 weeks. RESULTS Intranasally administered BMSCs were confirmed within spinal cord sections at both 2 and 4 weeks. The highest number, which was detected in the intrathecal BMSC-treated group at 2 weeks, was significantly higher than that in all the other groups. The BBB score of the intranasal BMSC-treated group showed statistically significant improvements by 1 week compared with the control group. However, in the final BBB scores, there was a statistically significant difference only between the intrathecal BMSC-treated group and the control group. The cavity ratios in the BMSC-treated groups were smaller than those of the control groups, but the authors did not find any significant differences in the NGF and BDNF levels in the CSF among the treatment and control groups. CONCLUSIONS BMSCs reached the injured spinal cord through the intranasal route and contributed to the recovery of hind limb motor function and lesion cavity reduction. However, the effects were not as significant as those seen in the intrathecal BMSC-treated group.


Journal of Neuroscience Methods | 2011

A new three-dimensional axonal outgrowth assay for central nervous system regeneration.

Masahiro Ishihara; Noriko Mochizuki-Oda; Koichi Iwatsuki; Haruhiko Kishima; Yumiko Iwamoto; Yu-ichiro Ohnishi; Masao Umegaki; Toshiki Yoshimine

Although recent studies have shown that cell transplantation is effective in promoting regeneration of the central nervous system (CNS) of adult mammals, functional recovery has been reported to be limited. In vitro models of axonal outgrowth assays are often used as easy methods for screening cells for transplantation but often fail to reflect the physiological conditions of in vivo CNS injury models. In order to bridge the gap between in vitro and in vivo models, we have established a new organotypic co-culture system comprising cortical tissue and a Matrigel containing several cell types that are candidates for transplantation therapy for CNS injury. In this model, cells transplanted in a Matrigel produce a three-dimensional architecture, with axons elongating from the cortex in the Matrigel. The ability of the transplanted cells to promote axonal growth was examined quantitatively by assessing axonal number and length. Moreover, we observed site-specific rearrangement of transplanted cells and interactions between axons and cells, including several cortical cells that migrated into the gel. These results indicate that our co-culture system can provide a useful assay for transplanted cells prior to in vivo screening.


Stem Cell Research | 2015

Isolation of human adult olfactory sphere cells as a cell source of neural progenitors

Yu-ichiro Ohnishi; Koichi Iwatsuki; Masahiro Ishihara; Takashi Shikina; Koei Shinzawa; Takashi Moriwaki; Koshi Ninomiya; Toshika Ohkawa; Masao Umegaki; Haruhiko Kishima; Toshiki Yoshimine

Olfactory stem cells are generated from olfactory mucosa. Various culture conditions generate olfactory stem cells that differ according to species and developmental stage and have different progenitor or stem cell characteristics. Olfactory spheres (OSs) are clusters of progenitor or stem cells generated from olfactory mucosa in suspension culture. In this study, adult human OSs were generated and their characteristics analyzed. Human OSs were adequately produced from olfactory mucosa with area over 40 mm(2). Immunocytochemistry (ICC) and fluorescence-activated cell sorting showed that human OSs were AN2 and A2B5-positive. Immunofluorescence analysis of cell type-specific ICC indicated that the number of Tuj1-positive OS cells was significantly elevated. Tuj1-positive cells displayed typical neuronal soma and dendritic morphology. Human OS cells were also immunopositive for MAP2. By contrast, few RIP-, O4-, and GFAP-positive cells were present. These RIP, O4, and GFAP-positive cells did not resemble bona fide oligodendrocytes and astrocytes morphologically. In culture to induce differentiation of oligodendrocytes, human OS cells also expressed neuronal markers, but neither oligodendrocyte or astrocyte markers. These findings suggest that human OS cells autonomously differentiate into neurons in our culture condition and have potential to be used as a cell source of neural progenitors for their own regenerative grafts, avoiding the need for immunosuppression and ethical controversies.


Spine | 2014

Presence of trans-synaptic neurons derived from olfactory mucosa transplanted after spinal cord injury.

Takashi Moriwaki; Koichi Iwatsuki; Noriko Mochizuki-Oda; Yu-ichiro Ohnishi; Masahiro Ishihara; Masao Umegaki; Koshi Ninomiya; Toshiki Yoshimine

Study Design. Using biotinylated dextran amine (BDA) and wheat germ agglutinin (WGA) tracers, we measured the effectiveness of olfactory mucosa (OM) transplantation as a scaffold in a rat model of chronic spinal cord injury (SCI). Objective. We examined whether OM transplantation for chronic SCI in rats results in reconstruction of neuronal pathways by both regeneration of the remaining axons and supply of OM-derived trans-synaptic neurons. Summary of Background Data. OM is one of the ideal scaffolds for axonal regeneration after chronic SCI. Methods. Rats received a mild contusion at vertebral level T6–T7. Two weeks after SCI, enhanced green fluorescent protein rat-derived OM, respiratory mucosa, and phosphate-buffered saline were transplanted into each group of SCI rats. Ten weeks after SCI, BDA was injected into the right sensorimotor cortex. Eleven weeks after SCI, WGA was injected into the L1–L2 posterior column to label the corticospinal tract retrogradely and trans-synaptically. Twelve weeks after SCI, rats were killed and their spinal cords were divided into cervical (area a), thoracic-injured (area b), and lower thoracic portions (area c). Immunohistochemically, sections of area (b) were evaluated by counting cells positive for enhanced green fluorescent protein, 4′,6-diamidino-2-phenylindole, WGA, and BDA (OM and respiratory mucosa groups). Axonal regenerations were estimated by counting WGA- and BDA-positive dots in transverse sections of area (a) and area (c). Results. Compared with respiratory mucosa and phosphate-buffered saline transplantation, OM transplantation increased the number of WGA-positive dots in area (a), and the number of BDA-positive dots in area (c) was more after OM transplantation than after phosphate-buffered saline transplantation. Furthermore, the number of quadruple-positive cells in area (b) was much higher after OM transplantation. Conclusion. Our results provide both indirect and direct evidence for the presence of trans-synaptic neurons. OM transplantation in rats with chronic SCI resulted in reconstruction of neural pathways by both providing trans-synaptic neurons and supporting regeneration of remaining axons. The olfactory mucosa is thought to be an efficacious scaffold to produce the relay neuron in chronic spinal cord injury. Level of Evidence: N/A


Journal of Neuroscience Research | 2014

Primary olfactory mucosal cells promote axonal outgrowth in a three‐dimensional assay

Masahiro Ishihara; Noriko Mochizuki-Oda; Koichi Iwatsuki; Haruhiko Kishima; Yu-ichiro Ohnishi; Takashi Moriwaki; Masao Umegaki; Toshiki Yoshimine

Among the possible sources of autologous cells and tissues for use in spinal cord injury grafts, one promising source is the olfactory mucosa containing olfactory ensheathing cells and neural progenitor cells. Olfactory mucosa transplantation for spinal cord injury has been effective in animal models and in pilot clinical trials. However, the contributions of olfactory ensheathing cells and neurons in olfactory mucosa are unclear. For the present study, we prepared primary olfactory mucosal cells and used a cortex–Matrigel coculture assay system to examine the axonal outgrowth of olfactory mucosa. Axonal outgrowth from cortical slices was significantly enhanced in olfactory mucosal cells compared with noncell controls and respiratory mucosal cells, which have few olfactory ensheathing cells and neurons. Axonal outgrowth was severely reduced after treatment with an antineurotrophin cocktail. A conditioned medium in the olfactory mucosa‐derived cell group contained neurotrophin‐3. Some olfactory ensheathing cells and almost all neurons were immunopositive for neurotrophin‐3. Axons originating from cortical slices targeted mainly the astrocyte‐like olfactory ensheathing cells. Our findings demonstrate that the axonal outgrowth effect of olfactory mucosa is supported by both olfactory ensheathing cells and neurons in olfactory mucosa.


Asian Spine Journal | 2013

Intradural Extramedullary Spinal Ependymoma: A Case Report of Malignant Transformation Occurring

Takashi Moriwaki; Koichi Iwatsuki; Yu-ichiro Ohnishi; Masao Umegaki; Masahiro Ishihara; Toshiki Yoshimine

Intradural extramedullary spinal ependymomas are extremely rare. Herein, we describe a lesion-type spinal ependymoma that followed a malignant course, and discuss its clinical presentation, etiopathogenesis, and treatment. We present a patient who was diagnosed with an intradural extramedullary spinal tumor at T4-T6. The patient underwent gross total resection of the tumor without damage to the spinal cord. Histological examination, classified the lesion as a World Health Organization (WHO)-grade 2 ependymoma. One and a half years later, magnetic resonance imaging detected a recurring tumor at T4-T5. The tumor was removed and classified as a WHO-grade 3 anaplastic ependymoma. The patient was started on a course of regional spinal cord radiotherapy. The patient achieved tumoral control and clinical stabilization after the recurrence. We must consider the differential diagnosis of intradural extramedullary spinal tumors. The best treatment for this lesion is gross total resection and adjunctive radiotherapy is necessary in cases of malignant-change.

Collaboration


Dive into the Yu-ichiro Ohnishi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge